Angiotensin receptor-blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) are two kinds of blood pressure-lowering agents that are also used to control proteinuria in early CKD patients on the basis of clinical practice guidelines. This evidence concerns the gene ACE and chronic kidney disease.